Abstract | BACKGROUND: AIM: METHODS: RESULTS: Mean total fat, protein and carbohydrate intake did not differ significantly between the groups. A significant difference in both fat and protein absorption occurred with the enzyme therapy groups. The Ultrase MT12 and Ultrase MT20 groups experienced a mean fat and protein absorption 79.4% and 83.8%, and 87.3% and 88.6%, respectively. No adverse events related to study drug were reported. CONCLUSIONS:
|
Authors | M W Konstan, R C Stern, J R Trout, J M Sherman, H Eigen, J S Wagener, C Duggan, M E B Wohl, P Colin |
Journal | Alimentary pharmacology & therapeutics
(Aliment Pharmacol Ther)
Vol. 20
Issue 11-12
Pg. 1365-71
(Dec 2004)
ISSN: 0269-2813 [Print] England |
PMID | 15606399
(Publication Type: Clinical Trial, Clinical Trial, Phase I, Clinical Trial, Phase II, Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Gastrointestinal Agents
- Lipase
|
Topics |
- Adolescent
- Adult
- Aged
- Child
- Cross-Over Studies
- Cystic Fibrosis
(complications)
- Double-Blind Method
- Exocrine Pancreatic Insufficiency
(drug therapy, etiology)
- Female
- Gastrointestinal Agents
(administration & dosage, adverse effects)
- Humans
- Lipase
(administration & dosage, adverse effects)
- Male
- Middle Aged
|